Eni Bushi | Pharmaceutical | Best Review Paper Award-7740

Posted on by Academic achievements

Dr. Eni Bushi | Pharmaceutical | Best Review Paper Award

Dr. Eni Bushi | Pharmaceutical – PhD student at University of Medicine Tirana, Albania

Eni Bushi (Beçi) is a dynamic pharmaceutical professional and researcher whose work bridges academia and the pharmaceutical industry. With extensive experience in pharmaceutical technology, quality assurance, and public health, she has made significant contributions both as a researcher and a leader in pharmaceutical practice. As the current Head of the Quality Assurance Department at Profarma sh.a. and a faculty member at the University of Medicine in Tirana, she plays a crucial role in shaping drug development standards and mentoring emerging professionals. A member of key scientific bodies such as NanoAlb and the Academy of Pharmacy “Eureka,” she exemplifies a strong commitment to advancing pharmaceutical knowledge through rigorous scientific inquiry and industry innovation.

Profile Verified

Scopus

Education

Eni Bushi holds a Master of Science in Pharmaceutical Sciences from the University of Medicine, Tirana, where she graduated with a perfect GPA and defended a thesis focused on prescription practices among elderly patients. Demonstrating her multidisciplinary outlook, she pursued a Master of Business Administration (MBA) at the University of New York Tirana, concentrating on healthcare management, with a thesis on Lean implementation in health systems. Currently, she is a PhD candidate in Pharmaceutical Technology at the same university, focusing on innovative semisolid formulations and their stability. Her academic journey has been enhanced by international certifications and professional development courses in nanotechnology, analytical validation, and Good Laboratory Practices.

Experience

Professionally, Eni Bushi has cultivated a strong career trajectory from community pharmacy to pharmaceutical manufacturing and research. Starting as a community pharmacist, she developed early experience in patient care and medication management. She then transitioned to Profarma sh.a., where she rose from Specialist to Head of the Quality Assurance Department, leading regulatory compliance, validation processes, and interdepartmental coordination. Simultaneously, she has served as a laboratory assistant and research mentor at the University of Medicine in Tirana. Her industry-academic hybrid role enables her to influence both pharmaceutical practice and education, while also fostering research innovation in drug development and regulatory science.

Research Interest

Eni Bushi’s research interests center on pharmaceutical technology, quality systems, antimicrobial resistance, and health systems improvement. Her current doctoral research focuses on semisolid drug formulations, with an emphasis on their physicochemical stability and comparative efficacy. She is particularly interested in integrating nanotechnology into drug delivery systems, and has pursued specialized training in nanomedicine. Her previous studies have explored the knowledge and behavior surrounding antibiotic use, as well as Lean strategies in healthcare environments. These interdisciplinary themes reflect her goal of advancing public health outcomes through innovation in drug formulation and pharmaceutical services.

Awards

Throughout her academic and professional journey, Eni Bushi has received recognition for her academic excellence and leadership. She was awarded the “Excellent Student” distinction by the University of Tirana’s Rectorate and has been consistently invited to contribute to international forums and scientific conferences. Her nomination for the Best Review Paper Award is underpinned by a record of impactful publications, academic mentorship, and a leadership role in pharmaceutical quality assurance.

Selected Publications

  1. 📘 Evaluation of the Knowledge, Attitude and Public Awareness about the Use of Antibiotic and Antibiotic Resistance in Albania (2024) – Indian Journal of Pharmaceutical Education and Research. Cited by 6 articles.
  2. 🧴 Formulation, Preparation and Evaluation of a Natural Cosmetic Product (2023) – Albanian Journal of Medical and Health Sciences. Cited by 3 articles.
  3. 🏥 Using Expert Consensus to Evaluate the Readiness Factors of Lean Implementation in Healthcare (2022) – International Journal of Scientific Research and Management. Cited by 9 articles.
  4. 👵 Prevalence and Factors Associated with Potentially Inappropriate Prescriptions among Older Patients at Hospital Discharge in Albania (2016) – Journal of Evaluation in Clinical Practice. Cited by 28 articles.
  5. 🧪 Theoretical Aspects of the Application of “Quality by Design” Approach in Drug Formulation (2025, Thesis Supervision) – Unpublished.
  6. 💊 Prevalence Assessment and Analysis of Self-Reported Use of Stimulant and Sedative Drugs among University Students (2023, Thesis Supervision) – University of Medicine, Tirana.
  7. 🧬 Analysis on the Level of Knowledge, Attitude, and Public Awareness Towards the Use of Antibiotics and Antimicrobial Resistance (2021, Thesis Supervision) – University of Medicine, Tirana.

Conclusion

Eni Bushi demonstrates a strong and evolving profile as a researcher, practitioner, and academic leader in the field of pharmaceutical sciences. Her combined background in pharmacy, business management, and pharmaceutical technology positions her uniquely to contribute to transformative change in drug formulation, health policy, and quality assurance. Her dedication to innovation, public health, and regulatory science makes her a highly deserving candidate for the Best Review Paper Award. Her work not only exemplifies academic excellence but also provides practical value to both the pharmaceutical industry and healthcare systems in Albania and beyond.

Stuart Maudsley | Pharmacology | Best Researcher Award

Posted on by Academic achievements

Prof. Dr. Stuart Maudsley | Pharmacology | Best Researcher Award

Prof. Dr. Stuart Maudsley | Pharmacology – Professor at Moffitt Cancer Center, United States

Dr. Stuart Russell Maudsley is an esteemed researcher and principal investigator whose work has had a profound impact on the field of pharmacology, particularly in the study of G-protein-coupled receptors (GPCRs). His career has been marked by significant contributions to cancer research, aging, and molecular gerontology, leading to the development of innovative therapeutic strategies aimed at treating complex human diseases. Dr. Maudsley’s work focuses on the precision targeting of GPCRs to develop treatments for a wide range of conditions, from cancer to neurodegenerative disorders, with a unique approach that blends basic science with clinical applications. He has been instrumental in leading transformative research at Moffitt Cancer Center and has earned widespread recognition for his contributions in both academia and industry.

Profile:

Scopus

Education:


Dr. Maudsley earned his Ph.D. in Pharmacology from the University of Leeds, UK, after completing a First-Class Bachelor’s degree in Pharmacology at the same institution. His doctoral research focused on electrophysiological and molecular biological studies of Tachykinin receptors, which set the stage for his continued exploration of receptor biology. His academic journey laid the groundwork for a career dedicated to uncovering the complex molecular mechanisms that regulate cellular behavior and how these processes can be manipulated for therapeutic purposes. His early education and research provided a foundation for his later innovations in the field of pharmacology and receptor therapeutics.

Experience:


Dr. Maudsley’s career spans several prestigious roles that highlight his leadership and expertise in pharmacology and receptor biology. He currently serves as the principal investigator at Moffitt Cancer Center, where he directs the Maudsley Lab, focusing on receptor biology and cancer therapeutics. His work is particularly notable for its precision in targeting GPCRs to treat cancer and other complex diseases. Dr. Maudsley also co-founded HeptOME – Receptor Therapeutics, and his position as a Special Science Advisor for the Belgian Superior Health Council reflects his international influence. His experience in both academic and industry settings has allowed him to bridge the gap between cutting-edge research and real-world therapeutic solutions.

Research Interests:


Dr. Maudsley’s primary research interest lies in the molecular and pharmacological study of GPCRs, a class of receptors that play a crucial role in various cellular processes. He focuses on understanding how these receptors regulate human diseases, particularly cancer, aging, and neurodegenerative disorders. By investigating the intricate mechanisms of GPCR signaling, Dr. Maudsley aims to develop novel targeted therapies that can improve treatment outcomes in these complex diseases. His research extends to systems pharmacology, which integrates multidimensional approaches to identify new drug targets and improve therapeutic strategies. Dr. Maudsley is particularly interested in the therapeutic application of GPCR-targeted medicines and their potential to treat diseases with unmet medical needs.

Awards:


Dr. Maudsley has received numerous accolades for his pioneering research in pharmacology and receptor biology. His work has been consistently recognized for its potential to revolutionize therapeutic strategies for cancer and aging-related diseases. He has been invited to speak at prestigious international conferences and has received several awards from scientific and medical societies for his contributions to understanding receptor biology. His recognition as a co-founder of HeptOME – Receptor Therapeutics further highlights his entrepreneurial spirit and ability to translate scientific discoveries into practical applications that benefit patients worldwide.

Publications:


Dr. Maudsley has an extensive publication record, contributing to major scientific journals and collaborative research projects. A few notable publications include:

  1. Maudsley S., Leysen H., van Gastel J., Martin B. (2021). Systems Pharmacology: Enabling Multidimensional Therapeutics, Reference Module in Biomedical Sciences. 📖
  2. Maudsley S., Schrauwen C., Harputluoğlu İ., Walter D., Leysen H., McDonald P. (2023). GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process, Int J Mol Sci. 🔬
  3. Schreurs G., Maudsley S., Nast C., Praet M., Da Silva Fernandes S., Boor P., D’Haese P., De Broe M.E., Vervaet B.A. (2023). Chronic Dehydration Induces Injury Pathways in Rats, Sci Rep. 🧪
  4. Maudsley S., Leysen H., Walter D., Vandoren R. (2023). GPCRs Regulate DNA Integrity, Encyclopedia – Biochemistry and Molecular Biology. 📑
  5. Coppens V., De Wachter O., Goossens J., Hendrix J., Maudsley S., Azmi A., van Gastel J., Van Saet A., Lauwers T., Morrens M. (2020). Profiling of Peripheral Blood Mononuclear Cells for Schizophrenia Biomarkers, Neuropsychobiology. 🧠
  6. Van Meenen J., Leysen H., Chen H., Baccarne R., Walter D., Martin B., Maudsley S. (2022). Making Biomedical Sciences Publications More Accessible for Machines, Med Health Care Philos. 💻
  7. Leysen H., Maudsley S., Van Gastel J., Martin B. (2021). The RXFP3 Receptor is a Modulator of Aging-Related Disease, Int J Mol Sci. 🧬

Conclusion:


Dr. Stuart Russell Maudsley’s extensive contributions to pharmacology, especially in the area of GPCRs and their role in complex diseases, make him an exceptional candidate for the Best Researcher Award. His research, which bridges the gap between basic science and clinical applications, continues to shape the future of precision medicine. Through his innovative work at Moffitt Cancer Center and his involvement in entrepreneurial ventures like HeptOME – Receptor Therapeutics, Dr. Maudsley has made a lasting impact on both academia and industry. His leadership in the field and his commitment to advancing therapeutic solutions for cancer, aging, and neurodegenerative diseases position him as a truly deserving nominee for this prestigious award.

Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

Posted on by Academic achievements

Ms.Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

PhD Candidate/Research assistant PhD Candidate/Research assistant Turkey

Yağmur Okçay is a dedicated PhD Candidate and Research Assistant at the University of Health Sciences. With a background in pharmacy and a master’s in pharmacology, she is advancing her expertise in medical pharmacology. Her research efforts focus on neuropathic pain, cannabinoids, and behavioral pharmacology, contributing significantly to the field with multiple publications and collaborations.

profile

ORCiD

Education 🎓

Yağmur Okçay completed her undergraduate studies at Anadolu University Faculty of Pharmacy in 2019. She then pursued a master’s degree in Pharmacology. Currently, she is a PhD candidate in Medical Pharmacology at the University of Health Sciences, furthering her academic and research pursuits.

Experience 🏫

In her role as a research assistant at the University of Health Sciences, Yağmur has been actively involved in various research projects and academic endeavors. Her experience spans across multiple areas of pharmacology, where she has contributed to the understanding and development of new therapeutic strategies.

Research Interests 🔬

Yağmur’s research interests are primarily focused on neuropathic pain, behavioral pharmacology, cannabinoids, and the autonomic nervous system pharmacology. Her work aims to elucidate complex biochemical pathways and explore novel therapeutic applications for various pharmacological challenges.

Awards 🏆

Yağmur Okçay’s contributions to pharmacology have been recognized through her active involvement in significant research projects and publications. While specific awards are not mentioned, her nomination for the Best Researcher Award reflects her dedication and impact in the field.

Publications 📄

  1. Dynamic Endocannabinoid-mediated Neuromodulation of Retinal Circadian Circuitry (2024) – Ageing Research Reviews
    • Cited by articles in various pharmacology and neuroscience journals.
  2. Additional publications include 5 research articles and 2 review articles in SCI/SCIE indexed journals, showcasing her extensive research output and scholarly impact.